Key result
Presentation after 2000 was associated with an increased median symptom duration for bone sarcomas (20 vs 16 weeks, p<0.01) and a slight decrease in soft tissue sarcoma size (9.6 vs 10.3 cm, p=0.03).
Population
4,934 patients referred to an orthopaedic oncology unit over 25 years
Design
Cohort
Authors
Loading...
No meaningful gains in sarcoma early diagnosis since 2000; leaves open whether awareness campaigns need redesign or better implementation.
Observational (n=4,934)
No
p-value: p=<0.01
Despite public health advice in 2000, there has been no clinically meaningful improvement in the early diagnosis of bone and soft tissue sarcomas over a 25-year period.
Smith et al. (2011) conducted an observational in Primary bone and soft tissue sarcomas (n=4,934). Presentation after the year 2000 vs. Presentation before the year 2000 was evaluated on Tumour size and symptom duration (p=<0.01). Presentation after 2000 was associated with an increased median symptom duration for bone sarcomas (20 vs 16 weeks, p<0.01) and a slight decrease in soft tissue sarcoma size (9.6 vs 10.3 cm, p=0.03).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: